- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.54 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 4 x 01: N-(6-amino-5-methylpyridin-3-yl)-2-{(2R,5S)-5-methyl-2-[2-(1-methylpiperidin-4-yl)-1,3-benzothiazol-5-yl]piperidin-1-yl}-2-oxoacetamide
01.2: 17 residues within 4Å:- Chain A: Q.317, S.318, L.320, E.328, V.334, F.335, E.443, L.445, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Chain C: H.155
- Ligands: MTA.1
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:Q.317, A:L.320, A:L.320, A:V.334, A:F.335, A:F.335, A:F.335, A:W.587, A:F.588
- Hydrogen bonds: A:Q.317, A:E.452, A:S.586, A:F.588
- Water bridges: A:L.320, A:N.451
- Salt bridges: A:E.328
- pi-Stacking: A:W.587
01.4: 17 residues within 4Å:- Chain A: H.155
- Chain C: Q.317, S.318, L.320, E.328, V.334, F.335, E.443, L.445, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.3
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:Q.317, C:L.320, C:L.320, C:L.320, C:V.334, C:F.335, C:F.335, C:F.335, C:W.587, C:F.588
- Hydrogen bonds: C:L.445, C:E.452, C:S.586, C:F.588
- Water bridges: C:E.452
- Salt bridges: C:E.328
01.7: 17 residues within 4Å:- Chain E: Q.317, S.318, L.320, E.328, V.334, F.335, E.443, L.445, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Chain G: H.155
- Ligands: MTA.6
17 PLIP interactions:17 interactions with chain E- Hydrophobic interactions: E:Q.317, E:L.320, E:L.320, E:V.334, E:F.335, E:F.335, E:F.335, E:W.587, E:F.588
- Hydrogen bonds: E:Q.317, E:E.452, E:S.586, E:F.588
- Water bridges: E:L.320, E:N.451
- Salt bridges: E:E.328
- pi-Stacking: E:W.587
01.9: 17 residues within 4Å:- Chain E: H.155
- Chain G: Q.317, S.318, L.320, E.328, V.334, F.335, E.443, L.445, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.8
16 PLIP interactions:16 interactions with chain G- Hydrophobic interactions: G:Q.317, G:L.320, G:L.320, G:L.320, G:V.334, G:F.335, G:F.335, G:F.335, G:W.587, G:F.588
- Hydrogen bonds: G:L.445, G:E.452, G:S.586, G:F.588
- Water bridges: G:E.452
- Salt bridges: G:E.328
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 4 residues within 4Å:- Chain C: Y.187, S.188, G.189, R.601
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:Y.187, C:S.188, C:G.189, C:R.601, C:R.601
EDO.10: 4 residues within 4Å:- Chain G: Y.187, S.188, G.189, R.601
5 PLIP interactions:5 interactions with chain G- Hydrogen bonds: G:Y.187, G:S.188, G:G.189, G:R.601, G:R.601
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. J.Med.Chem. (2025)
- Release Date
- 2025-03-12
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
AG
CB
BD
DF
BH
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.54 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 4 x 01: N-(6-amino-5-methylpyridin-3-yl)-2-{(2R,5S)-5-methyl-2-[2-(1-methylpiperidin-4-yl)-1,3-benzothiazol-5-yl]piperidin-1-yl}-2-oxoacetamide
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. J.Med.Chem. (2025)
- Release Date
- 2025-03-12
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
AG
CB
BD
DF
BH
D